Product overview

Tulopatch is a Tulobuterol transdermal patch designed for the long-acting management of bronchial asthma and chronic obstructive pulmonary disease (COPD).

It delivers Tulobuterol, a selective β₂-adrenergic receptor agonist, through the skin in a steady and controlled manner, ensuring smooth bronchodilation throughout the day and night.

This once-daily patch offers a convenient and non-invasive alternative to inhalers, improving patient comfort and compliance — especially for children and the elderly.

Therapeutic indications

Tulopatch is used for the management and relief of:

Bronchial asthma, Chronic obstructive pulmonary disease (COPD), Night-time and early morning asthma symptoms, Maintenance bronchodilator therapy

Key Features

Once-Daily Application – Provides 24-hour sustained bronchodilation.

Consistent Drug Delivery – Smooth and controlled absorption through the skin.

Convenient for All Ages – Ideal for patients who have difficulty using inhalers.

Non-Invasive and Comfortable – Easy to apply and remove, with minimal skin irritation.

Improved Compliance – Enhances long-term disease control through simplified thera

Mechanism of Action

Tulobuterol is a long-acting β₂-adrenergic receptor agonist (LABA) that relaxes bronchial smooth muscles by stimulating β₂ receptors, resulting in airway dilation and improved airflow.

Through transdermal delivery, Tulopatch maintains steady plasma levels of Tulobuterol, ensuring continuous symptom control for up to 24 hours.